TLR9 agonists induced cell death in Burkitt's lymphoma cells is variable and influenced by TLR9 polymorphism

Toll-like receptor 9 (TLR9) triggering is a promising novel strategy to combat cancer as it induces innate and adaptive immunity responses. B-cell lymphoma is unique in this context as tumor cells express TLR9 and may harbor latent Epstein-Barr virus (EBV), a gamma-herpesvirus with remarkable oncoge...

Descripción completa

Detalles Bibliográficos
Autores principales: Noack, J, Jordi, M, Zauner, L, Alessi, D, Burch, A, Tinguely, M, Hersberger, M, Bernasconi, M, Nadal, D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388232/
https://www.ncbi.nlm.nih.gov/pubmed/22717578
http://dx.doi.org/10.1038/cddis.2012.60

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388232/
https://www.ncbi.nlm.nih.gov/pubmed/22717578
http://dx.doi.org/10.1038/cddis.2012.60

Ejemplares similares